We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$155M
AUM Growth
-$162K
Cap. Flow
-$1.44M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.34%
Holding
104
New
5
Increased
29
Reduced
43
Closed
6

Top Buys

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$1.32M
2
NVO
Novo Nordisk
NVO
+$995K
3
NKE icon
Nike
NKE
+$760K
4
CAH icon
Cardinal Health
CAH
+$598K
5
DIS icon
Walt Disney
DIS
+$525K

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$1.73M
2
SAM icon
Boston Beer
SAM
+$1.3M
3
FAST icon
Fastenal
FAST
+$1M
4
JWN
Nordstrom
JWN
+$708K
5
DHR icon
Danaher
DHR
+$558K

Sector Composition

Rank Sector Weight
1 Consumer Staples 27.19%
2 Healthcare 18.49%
3 Financials 16.89%
4 Communication Services 8.23%
5 Industrials 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
76
CVS Health
CVS
$134B
$568K 0.37%
6,384
+203
+3% +$19.2K
SCZ icon
77
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$564K 0.36%
10,761
– –
FAST icon
78
Fastenal
FAST
$53.5B
$555K 0.36%
53,100
-94,300
-64% -$1M
BNS icon
79
Scotiabank
BNS
$107B
$551K 0.36%
10,400
– –
JPM icon
80
JPMorgan Chase
JPM
$933B
$488K 0.31%
7,335
+4
+0.1% +$261
NQP
81
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$477K 0.31%
32,000
– –
GFF icon
82
Griffon
GFF
$4.03B
$437K 0.28%
25,675
– –
MON
83
DELISTED
Monsanto Co
MON
$429K 0.28%
4,196
– –
INTC icon
84
Intel
INTC
$460B
$428K 0.28%
11,329
-1,886
-14% -$66.8K
KDP icon
85
Keurig Dr Pepper
KDP
$43B
$365K 0.24%
4,000
– –
META icon
86
Meta Platforms (Facebook)
META
$1.37T
$296K 0.19%
2,308
+58
+3% +$7.2K
ABEV icon
87
Ambev
ABEV
$48.2B
$293K 0.19%
48,050
-1,800
-4% -$10.8K
IJH icon
88
iShares Core S&P Mid-Cap ETF
IJH
$122B
$291K 0.19%
9,420
– –
ORLY icon
89
O'Reilly Automotive
ORLY
$72.4B
$285K 0.18%
15,255
– –
GIS icon
90
General Mills
GIS
$19.4B
$272K 0.18%
4,259
– –
BMY icon
91
Bristol-Myers Squibb
BMY
$132B
$260K 0.17%
4,825
– –
IBM icon
92
IBM
IBM
$209B
$249K 0.16%
+1,642
New +$249K
MRK icon
93
Merck
MRK
$321B
$241K 0.16%
4,041
– –
DLX icon
94
Deluxe
DLX
$1.19B
$234K 0.15%
3,500
– –
SLB icon
95
SLB Ltd
SLB
$72.6B
$232K 0.15%
2,950
– –
SMB icon
96
VanEck Short Muni ETF
SMB
$312M
$221K 0.14%
12,500
– –
BRK.A icon
97
Berkshire Hathaway Class A
BRK.A
$1.1T
$216K 0.14%
1
– –
APC
98
DELISTED
Anadarko Petroleum
APC
$203K 0.13%
+3,208
New +$179K
JWN
99
DELISTED
Nordstrom
JWN
– –
-18,615
Closed -$708K
PPL
100
PPL Corp
PPL
$26.8B
– –
-8,000
Closed -$302K
1 2 3
4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
BDWCC
B&D White Capital Company Lakeway, Texas $809M AUM 19.33% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return

Kavar Capital Partners Group's Q3 2016 Portfolio in Review

As of Q3 2016, Kavar Capital Partners Group held 104 positions worth $155M, down 0.1% from $155M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Kavar Capital Partners Group's Q3 2016 filing shows 5 new, 29 increased, 43 reduced and 6 closed positions. Its largest new stake was Vodafone: 43,350 shares worth $1.26M. The largest sale was Viatris, an estimated $1.73M.

By sector, the portfolio is most concentrated in Consumer Staples at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Kavar Capital Partners Group's largest Q3 2016 buy was Vodafone: 43,350 shares worth $1.26M.
  • Kavar Capital Partners Group added most to Cardinal Health in Q3 2016, an estimated $598K increase.
  • Kavar Capital Partners Group's biggest Q3 2016 reduction was Fastenal, cutting an estimated $1M.
  • Kavar Capital Partners Group fully exited Viatris in Q3 2016, selling an estimated $1.73M.
  • Kavar Capital Partners Group's ten largest holdings make up 23% of its $155M portfolio in Q3 2016.
  • Kavar Capital Partners Group opened 5 new positions and closed 6 in Q3 2016.
  • Kavar Capital Partners Group's portfolio value fell 0.1% quarter-over-quarter to $155M.

Based on Kavar Capital Partners Group's 13F filing for Q3 2016, filed 15 May 2019.